Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Standard group: Given Haloperidol at 1.25 mg/kg (i.p.) in combination with L-dopa at 10 mg/kg for 21 days
:max_bytes(150000):strip_icc()/VWH-GettyImages-2126120259-c2442d334436484baa255439265b7fb1.jpg)
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (Mounjaro) and chronic weight management (Zepbound) in adults with BMI 30 kg/m or 27 kg/m with at least one weight-related comorbidity
Triple, quadruple and quintuple agonists are now in development, as is an expanded range of oral formulations
Montelius et al., 2014)
Retrieved from Li, Y., Su, Z., Li, P., et al
US$ 20.14
US$ 22.55
US$ 25.70
US$ 25.08
US$ 24.79
US$ 20.34
US$ 20.68
US$ 23.95
US$ 28.21
US$ 23.93
US$ 26.59
